Cell Line News and Research

RSS

Researchers take promising step forward in the battle against HIV

A multi-institutional research group led by researchers from Tokyo Medical and Dental University (TMDU) has made a significant and promising step forward in our ability to treat human immunodeficiency virus type 1 (HIV-1), the virus underlying acquired immunodeficiency syndrome (AIDS).

21 Jun 2023

3D-printed vaginal ovules offer promising treatment for endometriosis

3D-printed vaginal ovules offer controlled release and targeted treatment, showing promise for conditions like endometriosis.

20 Jun 2023

Catalent expands OneBio® suite for integrated development, manufacturing and supply across biologic modalities

Catalen today announced that it has expanded its integrated development, manufacturing and supply solution, OneBio® Suite, across a range of biologic modalities, including antibody and recombinant proteins, cell and gene therapies, and mRNA.

From Catalent 16 Jun 2023

Meat-free minerals: the mineral content, bioaccessibility, and bioavailability of iron and zinc vegetarian and vegan burgers

Researchers compared the mineral content and absorption of plant-based meat-free (vegan and vegetarian) burgers and beef burgers.

15 Jun 2023

Analyzing the role of LP-284 Hodgkin's lymphoma models and in DNA damage repair

A new research paper was published in Oncotarget's Volume 14 on June 12, 2023, entitled, "LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin's lymphoma models and in cells deficient in DNA damage repair."

13 Jun 2023

H.E.L Group expands range of BioXplorer bioreactors to support bioprocess development

H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization.

From H.E.L Group 8 Jun 2023

New strategy to grow and measure how tumor organoids respond to therapy

Scientists from the UCLA Jonsson Comprehensive Cancer Center have developed a new method to bioprint miniature tumor organoids that are designed to mimic the function and architecture of real tumors. The improved process allows researchers to use an advanced imaging method to study and analyze individual organoids in great detail, which can help researchers identify personalized treatments for people with rare or hard-to-treat cancers.

7 Jun 2023

CBD and EPA cream: Dynamic duo for youthful skin

A recent study examines the anti-aging potential of a new cream formulation that contains CBD and EPA.

6 Jun 2023

ISSCR proposes new guidelines for using stem cells in research

The International Society for Stem Cell Research (ISSCR) today released the ISSCR Standards for Human Stem Cell Use in Research, an international collaboration aimed at enhancing rigor in preclinical research and ultimately strengthening the pipeline of therapies for patients.

6 Jun 2023

RNA regulatory mechanism could be targeted to slow AD progression mediated by stress granules

A new research paper was published on the cover of Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 10, entitled, "Stress granules sequester Alzheimer's disease-associated gene transcripts and regulate disease-related neuronal proteostasis."

1 Jun 2023

Lipid-degrading enzyme, fatty acid amide hydrolase is a predictor of long-term survival in patients with breast cancer

Scientists have identified a lipid-degrading enzyme as a prognostic biomarker for luminal breast cancer.

31 May 2023

Novel assay for identifying individuals with synucleinopathies using serum samples

Synucleinopathies are a group of neurodegenerative diseases caused by the abnormal accumulation α-synuclein, a protein normally found in the brain and neurons. Incorrect folding of α-synuclein leads to formation of 'seeds', which attract more α-synuclein proteins to form larger clumps.

29 May 2023

Scientists unveil a metabolic Achilles' heel in pancreatic cancer

Research unveils the significance of uridine as a metabolic fuel in pancreatic ductal adenocarcinoma (PDA) cells under glucose-deprived conditions. Uridine utilization, mediated by uridine phosphorylase 1 (UPP1), supports redox balance, survival, and proliferation in PDA, highlighting its potential as a novel therapeutic target in the treatment of this resistant cancer.

23 May 2023

Cell Line News and Research

Researchers take promising step forward in the battle against HIV

3D-printed vaginal ovules offer promising treatment for endometriosis

Catalent expands OneBio® suite for integrated development, manufacturing and supply across biologic modalities

Meat-free minerals: the mineral content, bioaccessibility, and bioavailability of iron and zinc vegetarian and vegan burgers

Analyzing the role of LP-284 Hodgkin's lymphoma models and in DNA damage repair

H.E.L Group expands range of BioXplorer bioreactors to support bioprocess development

New strategy to grow and measure how tumor organoids respond to therapy

CBD and EPA cream: Dynamic duo for youthful skin

ISSCR proposes new guidelines for using stem cells in research

RNA regulatory mechanism could be targeted to slow AD progression mediated by stress granules

Lipid-degrading enzyme, fatty acid amide hydrolase is a predictor of long-term survival in patients with breast cancer

Novel assay for identifying individuals with synucleinopathies using serum samples

Scientists unveil a metabolic Achilles' heel in pancreatic cancer

New vaccine concept could lead to a new generation of vaccines against SARS-CoV-2

PhenomeX Launches Beacon Select™ Optofluidic System with Opto® B Discovery Workflows

HER2-TPMC proves to be a reasonable alternative for HER2-positive cancer chemotherapeutics

Leveraging proteomics datasets to discover potential therapeutic targets for cancer patients

Sphere Fluidics appoints Kenneth Hitchner as Chairman of its Board of Directors

Study evaluates the effects of phenolic compounds in extra virgin olive oil on skin health

Researchers investigate the roles of STAT3α and STAT3β isoforms in aggressive breast cancer

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News